$ACTG

Kohlberg Isaac T. sold $109K of ACTG

Kohlberg Isaac T. sold 24,000 shares of ACACIA RESEARCH CORP (ACTG) at $4.55 ($0.11M total) on 2026-09-15.

Original reporting
SEC EDGAR · Kohlberg Isaac T.
Published Sep 16, 2026, 9:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACTG
Bearish
medium confidence
Mentioned
$ACTG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACTGBearishLow
01

Why it matters

The sale is modest and unlikely to move the stock significantly, but it adds to the flow of insider activity data.

02

Market read

Provides fresh insider transaction data; low immediate trading relevance.

03

What to watch

Potential upcoming corporate actions or strategic shifts not disclosed.

Relevance 4/10Novelty 5/10Timing: post-market filing on 2026-09-15

Background

Form 4 filings disclose insider transactions; investors monitor for signals of confidence.

Company-level read

Ticker impact

$ACTGBearishMedium confidence
Context

Director Kohlberg Isaac T. sold 24,000 shares for $109,200 on 2026-09-15, reducing his stake to 54,310 shares.

Expected impact

Possible slight dip in ACTG price as market absorbs insider sell.

Evidence & confidence

Sale size is modest relative to market cap and below $1M, typical for routine diversification.

Market effects

Limited impact on the broader specialty finance sector.

No significant regional effect.

Minimal global relevance.

Counterpoint

Insider sale may be unrelated to company fundamentals; could be a routine portfolio rebalancing.

Key entities

  • Acacia Research Corp

    NASDAQ-listed specialty finance company.

  • Kohlberg Isaac T.

    Director of Acacia Research Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACTGMedAI 8/10

Acacia Research (ACTG) Q2 2026 Earnings Call Transcript

Acacia Research (ACTG) reported Q2 2026 revenue of $114.6 million, up from $51.2 million a year earlier, mainly from a $60.9 million IP licensing settlement with TP-Link. Adjusted diluted EPS was $0.13. GAAP net income was $47,000, including a $30.9 million noncash impairment tied to Life Sciences holdings. Cash and liquidity were $334.6 million.